Cabot Corporation CBT · NYSE
$74.44 +0.80% (+$0.59)
Summary
72 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 18% a year over the last 3 years.
- It has raised its dividend 14 years in a row and pays out only 50% of profit.
- It bought back its own shares for $168.0M in the last fiscal year, 4.4% of its market value.
- Out of every 100 USD of revenue, 7.7 USD is left as free cash.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue fell by 4.9% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 20.1 USD for 1 USD of yearly profit. Over the last five years it was 13.3 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.3% a year over 5 years. Over the last 3 years it fell by 4.9% a year. Earnings per share grew by 18% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 77 USD
- Research and development 1.5 USD
- Sales and administration 7.6 USD
- Taxes and other 8.6 USD
- Net profit 5.2 USD
Net profit, industry median (Chemicals - Specialty) 6.0 USD
Out of every 100 USD of revenue, 5.2 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.50%
- Paid out of profit
- 50%
- Raised in a row
- 14 years
You receive $1.84 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 7
- Sell 1
Today's price within the analysts' price targets
The average target of $94 is 26% above today's price. 47% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reinforcement Materials 65%
- Performance Chemicals 35%
By region
- Asia Pacific 39%
- Americas 37%
- EMEA 24%
Reinforcement Materials brings in 65% of revenue.
Segments in detail